Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)
HKD 1.3
(-2.99%)
HKD 1.3
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 63.52 Million | 95.74 Million | 152.8 Million | 486.28 Million | - | - |
| Cost of Revenue | 60.31 Million | 83.11 Million | 139.97 Million | 44.11 Million | - | - |
| Gross Profit | 3.2 Million | 12.63 Million | 12.83 Million | 442.17 Million | - | - |
| Operating Expenses | 401.08 Million | 487.36 Million | 315.15 Million | 232.78 Million | 200.43 Million | 105.29 Million |
| Selling, General and Administrative Expenses | 46.61 Million | 42.55 Million | 16.88 Million | 53.83 Million | 3.04 Million | 5.91 Million |
| Research and Development Expenses | 372.32 Million | 445.64 Million | 280.83 Million | 185.95 Million | 138.97 Million | 84.88 Million |
| Other Expenses | -17.85 Million | -830 Thousand | 17.43 Million | -7 Million | 58.41 Million | -52.9 Million |
| Cost and Expenses | 461.39 Million | 570.48 Million | 455.13 Million | 276.89 Million | 200.43 Million | 105.29 Million |
| Operating Income | -397.87 Million | -474.73 Million | -302.32 Million | 179.11 Million | -194.17 Million | -101.43 Million |
| Interest Expense | 8.31 Million | 2.27 Million | 568 Thousand | 1.22 Million | 1.37 Million | 2.04 Million |
| Income Tax Expense | - | 3.02 Million | -8.9 Million | 1.69 Billion | 235.97 Million | -48.59 Million |
| Earnings before Tax | -359.11 Million | -371.86 Million | -301.18 Million | -1.51 Billion | -425.81 Million | -155.93 Million |
| Net Income | -359.11 Million | -374.88 Million | -292.28 Million | -3.2 Billion | -661.79 Million | -149.21 Million |
| Earnings Per Share Basic | -0.46 | -0.50 | -0.39 | -8.42 | -0.87 | -0.20 |
| Earnings Per Share Diluted | -0.46 | -0.50 | -0.39 | -8.42 | -0.87 | -0.20 |
| Weighted Average Shares Outstanding | 772.84 Million | 751.87 Million | 747.29 Million | 381.02 Million | 759.65 Million | 759.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 772.84 Million | 751.87 Million | 747.29 Million | 381.02 Million | 759.65 Million | 759.65 Million |
| Gross Margin | 0.05 | 0.13 | 0.08 | 0.91 | - | - |
| EBIT Margin | -5.13 | -3.68 | -1.96 | 0.39 | - | - |
| Profit Margin | -5.65 | -3.92 | -1.91 | -6.60 | - | - |
| EBITDA | -325.72 Million | -355.79 Million | -289.82 Million | -1.5 Billion | -175.65 Million | -92.37 Million |
| Earnings Before Tax Margin | -6.26 | -4.96 | -1.98 | 0.37 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 11.59 Million | 63.52 Million | 11.59 Million | 20.16 Million |
| Cost of Revenue | - | - | 11.19 Million | 60.31 Million | 11.19 Million | 18.96 Million |
| Gross Profit | - | - | 400.5 Thousand | 3.2 Million | 400.5 Thousand | 1.2 Million |
| Operating Expenses | 92.94 Million | 92.94 Million | 107.05 Million | 411.43 Million | 107.05 Million | 93.48 Million |
| Selling, General and Administrative Expenses | 10.59 Million | 10.59 Million | 11.45 Million | - | 11.45 Million | 11.85 Million |
| Research and Development Expenses | 88.41 Million | 88.41 Million | 86.78 Million | - | 86.78 Million | 99.37 Million |
| Other Expenses | -6.06 Million | -6.06 Million | 8.82 Million | - | - | - |
| Cost and Expenses | 92.94 Million | 92.94 Million | 118.25 Million | 471.74 Million | 118.25 Million | 112.44 Million |
| Operating Income | -92.94 Million | -92.94 Million | -106.65 Million | -397.87 Million | -94.92 Million | -111.05 Million |
| Interest Expense | - | - | - | 8.31 Million | - | 4.26 Million |
| Income Tax Expense | -2.33 Million | -2.33 Million | 11.73 Million | 71.48 Million | - | -3.00 |
| Earnings before Tax | -84.52 Million | -84.52 Million | -96.41 Million | -359.11 Million | -96.41 Million | -83.14 Million |
| Net Income | -84.52 Million | -84.52 Million | -96.41 Million | -359.11 Million | -96.41 Million | -83.14 Million |
| Earnings Per Share Basic | -0.11 | -0.11 | -0.12 | - | -0.12 | -0.11 |
| Earnings Per Share Diluted | -0.11 | -0.11 | -0.12 | - | -0.12 | -0.11 |
| Weighted Average Shares Outstanding | 776.65 Million | 776.65 Million | 775.91 Million | 772.84 Million | 775.91 Million | 769.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 776.65 Million | 776.65 Million | 775.91 Million | 772.84 Million | 775.91 Million | 769.77 Million |
| Gross Margin | - | - | 0.03 | 0.05 | 0.03 | 0.06 |
| EBIT Margin | - | - | -8.15 | - | -8.15 | -5.26 |
| Profit Margin | - | - | -8.32 | -5.65 | -8.32 | -4.12 |
| EBITDA | -88.4 Million | -88.4 Million | -94.48 Million | - | -94.48 Million | -106.07 Million |
| Earnings Before Tax Margin | - | - | -9.20 | -6.26 | -8.19 | -5.51 |
PEN
NCPLW
BP
3265
002193
2165